Skip to content

SelectQuote SLQT Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

IRA
Iris Acquisition IRAB
$10.61M
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$297K+119%
EPM
Evolution PetroleumEPM
$78K+11.4%
TRV
Trevi Therapeutics, Inc.TRVI
$0
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$65.65K+260%
New Horizon Aircraft logo
New Horizon AircraftHOVR
$510K

Other financials

Income statement

See full
Revenue$430.9M+5.6%
Gross profit$259.6M+5.6%
Operating income$35.9M+62.9%
Net income$40.2M+54.5%
EPS (diluted)$0.11+267%

Balance sheet

See full
Cash & equivalents$35.2M-59.2%
Total debt$404.8M-4.5%
Total equity$384.7M+9.9%
Total assets$1.3B+3.0%

Cash flow

See full
Operating cash flow$56.8M-20.2%
CapEx$947.0K-0.2%
Free cash flow$55.8M-20.4%

Valuation

See full
Market cap$139.42M-65.1%
Enterprise value$509.04M-34.8%
P/E1.5×-6.9×
P/S0.1×-0.2×

Profitability

See full
Gross margin54.2%-7.6pp
Operating margin5.4%
Net margin5.6%+5.3pp
FCF margin-0.4%-3.3pp

Returns & leverage

See full
Return on equity25%+23.9pp
Debt / equity1.1×-0.2×
Current ratio1.6×-0.3×

Where this comes from

Reported directly by SelectQuote in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: SelectQuote’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about SelectQuote's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SelectQuote's payments of stock issuance costs?
SelectQuote (SLQT) reported payments of stock issuance costs of -$7.1M in Q1 2026.
How has SelectQuote's payments of stock issuance costs changed year-over-year?
SelectQuote's payments of stock issuance costs decreased by 501.4% year-over-year, from $1.77M to -$7.1M.
What does payments of stock issuance costs mean?
Refers to the direct costs incurred, such as legal, accounting, and underwriting fees, associated with issuing new equity securities. Tracking these costs helps assess the efficiency of the company's capital-raising activities.